Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 179

1.

First Report of Perfluorobutane Microsphere Enhanced Ultrasound in the Transplant Kidney.

Siedlecki AM, Benson C, Frates M, Azzi J, Hoffman RJ, Milford E, Weins A, Chandraker A, Mc Donald N, White JP, Abdi R.

Transplantation. 2019 Jun 27. doi: 10.1097/TP.0000000000002856. [Epub ahead of print] No abstract available.

PMID:
31335773
2.

Accelerated Allograft Vasculopathy With Rituximab After Cardiac Transplantation.

Starling RC, Armstrong B, Bridges ND, Eisen H, Givertz MM, Kfoury AG, Kobashigawa J, Ikle D, Morrison Y, Pinney S, Stehlik J, Tripathi S, Sayegh MH, Chandraker A; CTOT-11 Study Investigators.

J Am Coll Cardiol. 2019 Jul 9;74(1):36-51. doi: 10.1016/j.jacc.2019.04.056.

PMID:
31272550
3.

Preformed Donor-specific Antibodies Against HLA Class II and Graft Outcomes in Deceased-donor Kidney Transplantation.

Uffing A, Hidalgo LG, McMullan C, Perry J, Milford EL, Murakami N, Yeung MY, Guleria I, Wood IG, Akalin E, Azzi J, Chandraker AK, Riella LV.

Transplant Direct. 2019 Apr 15;5(5):e446. doi: 10.1097/TXD.0000000000000893. eCollection 2019 May.

4.

Cell Therapy in Solid Organ Transplantation.

Cai S, Chandraker A.

Curr Gene Ther. 2019;19(2):71-80. doi: 10.2174/1566523219666190603103840.

PMID:
31161989
5.

Five-Year Follow-up after Face Transplantation.

Tasigiorgos S, Kollar B, Turk M, Perry B, Alhefzi M, Kiwanuka H, Nizzi MC, Marty FM, Chandraker A, Tullius SG, Riella LV, Pomahac B.

N Engl J Med. 2019 Jun 27;380(26):2579-2581. doi: 10.1056/NEJMc1810468. Epub 2019 May 29. No abstract available.

PMID:
31141626
6.

Potential Roles of Siglecs in the Regulation of Allo-Immune Reaction.

Cai S, Zhao J, Ueno T, Chandraker A.

Curr Protein Pept Sci. 2019;20(8):823-828. doi: 10.2174/1389203720666190507095759.

PMID:
31060487
7.

Time for reform in transplant program-specific reporting: AST/ASTS transplant metrics taskforce.

Chandraker A, Andreoni KA, Gaston RS, Gill J, Locke JE, Mathur AK, Norman DJ, Patzer RE, Rana A, Ratner LE, Schold JD, Pruett TL; AST/ASTS Transplant Metrics Taskforce.

Am J Transplant. 2019 Jul;19(7):1888-1895. doi: 10.1111/ajt.15394. Epub 2019 May 23.

PMID:
31012525
8.

Novel Targets of Immunosuppression in Transplantation.

Shin HS, Grgic I, Chandraker A.

Clin Lab Med. 2019 Mar;39(1):157-169. doi: 10.1016/j.cll.2018.10.008. Epub 2018 Dec 18. Review.

PMID:
30709504
9.

Erratum.

Palsson R, Chandraker AK, Curhan GC, Rennke HG, McMahon GM, Waikar SS.

Nephrol Dial Transplant. 2018 Dec 22. doi: 10.1093/ndt/gfy364. [Epub ahead of print] No abstract available.

PMID:
30590582
10.

Early immune biomarkers and intermediate-term outcomes after heart transplantation: Results of Clinical Trials in Organ Transplantation-18.

Stehlik J, Armstrong B, Baran DA, Bridges ND, Chandraker A, Gordon R, De Marco T, Givertz MM, Heroux A, Iklé D, Hunt J, Kfoury AG, Madsen JC, Morrison Y, Feller E, Pinney S, Tripathi S, Heeger PS, Starling RC.

Am J Transplant. 2019 May;19(5):1518-1528. doi: 10.1111/ajt.15218. Epub 2019 Jan 22.

PMID:
30549425
11.

The Lifetime Health Burden of Delayed Graft Function in Kidney Transplant Recipients in the United States.

Incerti D, Summers N, Ton TGN, Boscoe A, Chandraker A, Stevens W.

MDM Policy Pract. 2018 Jun 17;3(1):2381468318781811. doi: 10.1177/2381468318781811. eCollection 2018 Jan-Jun.

12.

New England BK consortium: Regional survey of BK screening and management protocols in comparison to published consensus guidelines.

Gabardi S, Pavlakis M, Tan C, Francis J, Cardarelli F, Asch W, Bodziak K, Chobanian M, Gilligan H, Gohh R, Kung SC, Inker L, Martin S, Rodig N, Rossi A, Chandraker A.

Transpl Infect Dis. 2018 Dec;20(6):e12985. doi: 10.1111/tid.12985. Epub 2018 Sep 19.

PMID:
30175491
13.

The association of calcium oxalate deposition in kidney allografts with graft and patient survival.

Palsson R, Chandraker AK, Curhan GC, Rennke HG, McMahon GM, Waikar SS.

Nephrol Dial Transplant. 2018 Aug 27. doi: 10.1093/ndt/gfy271. [Epub ahead of print]

PMID:
30165691
14.

P2X7R mutation disrupts the NLRP3-mediated Th program and predicts poor cardiac allograft outcomes.

D'Addio F, Vergani A, Potena L, Maestroni A, Usuelli V, Ben Nasr M, Bassi R, Tezza S, Dellepiane S, El Essawy B, Iascone M, Iacovoni A, Borgese L, Liu K, Visner G, Dhe-Paganon S, Corradi D, Abdi R, Starling RC, Folli F, Zuccotti GV, Sayegh MH, Heeger PS, Chandraker A, Grigioni F, Fiorina P.

J Clin Invest. 2018 Aug 1;128(8):3490-3503. doi: 10.1172/JCI94524. Epub 2018 Jul 16.

15.

Recurrent membranous nephropathy and acute cellular rejection in a patient treated with direct anti-HCV therapy (ledipasvir/sofosbuvir).

Murakami N, Ding Y, Cohen DJ, Chandraker AK, Rennke HG.

Transpl Infect Dis. 2018 Oct;20(5):e12959. doi: 10.1111/tid.12959. Epub 2018 Jul 23.

PMID:
29968947
16.

Characterising N-acetylglucosaminylphosphatidylinositol de-N-acetylase (CaGpi12), the enzyme that catalyses the second step of GPI biosynthesis in Candida albicans.

Yadav U, Rai TK, Sethi SC, Chandraker A, Khan MA, Komath SS.

FEMS Yeast Res. 2018 Nov 1;18(7). doi: 10.1093/femsyr/foy067.

PMID:
29945236
17.

Regulatory T Cells and Kidney Transplantation.

Martin-Moreno PL, Tripathi S, Chandraker A.

Clin J Am Soc Nephrol. 2018 Nov 7;13(11):1760-1764. doi: 10.2215/CJN.01750218. Epub 2018 May 22. Review.

PMID:
29789350
18.

Sensitization in Transplantation: Assessment of Risk (STAR) 2017 Working Group Meeting Report.

Tambur AR, Campbell P, Claas FH, Feng S, Gebel HM, Jackson AM, Mannon RB, Reed EF, Tinckam K, Askar M, Chandraker A, Chang PP, Colvin M, Demetris AJ, Diamond JM, Dipchand AI, Fairchild RL, Ford ML, Friedewald J, Gill RG, Glotz D, Goldberg H, Hachem R, Knechtle S, Kobashigawa J, Levine DJ, Levitsky J, Mengel M, Milford E, Newell KA, O'Leary JG, Palmer S, Randhawa P, Smith J, Snyder L, Starling RC, Sweet S, Taner T, Taylor CJ, Woodle S, Zeevi A, Nickerson P.

Am J Transplant. 2018 Jul;18(7):1604-1614. doi: 10.1111/ajt.14752. Epub 2018 May 22.

19.

Analysis of dendritic cells and ischemia-reperfusion changes in postimplantation renal allograft biopsies may serve as predictors of subsequent rejection episodes.

Batal I, Mohan S, De Serres SA, Vasilescu ER, Tsapepas D, Crew RJ, Patel SS, Serban G, McCune K, Husain SA, Chang JH, Herter JM, Bhagat G, Markowitz GS, D'Agati VD, Hardy MA, Ratner L, Chandraker A.

Kidney Int. 2018 May;93(5):1227-1239. doi: 10.1016/j.kint.2017.12.015. Epub 2018 Mar 13.

PMID:
29544662
20.

Eponychial lesions following bilateral upper extremity vascular composite allotransplantation: a case report.

Fallahian F, Molway D, Jadeja S, Clark R, Marty FM, Riella LV, Chandraker A, Talbot SG.

Case Reports Plast Surg Hand Surg. 2018 Feb 2;5(1):14-17. doi: 10.1080/23320885.2018.1431047. eCollection 2018.

21.

Upregulated Heat Shock Proteins After Hyperthermic Chemotherapy Point to Induced Cell Survival Mechanisms in Affected Tumor Cells From Peritoneal Carcinomatosis.

Grimmig T, Moll EM, Kloos K, Thumm R, Moench R, Callies S, Kreckel J, Vetterlein M, Pelz J, Polat B, Tripathi S, Rehder R, Ribas CM, Chandraker A, Germer CT, Waaga-Gasser AM, Gasser M.

Cancer Growth Metastasis. 2017 Sep 18;10:1179064417730559. doi: 10.1177/1179064417730559. eCollection 2017.

22.

Expanding clarity or confusion? Volatility of the 5-tier ratings assessing quality of transplant centers in the United States.

Schold JD, Andreoni KA, Chandraker AK, Gaston RS, Locke JE, Mathur AK, Pruett TL, Rana A, Ratner LE, Buccini LD.

Am J Transplant. 2018 Jun;18(6):1494-1501. doi: 10.1111/ajt.14659. Epub 2018 Feb 9.

23.

Significance of biologics in renal transplantation: past, present, and future.

Grgic I, Chandraker A.

Curr Opin Organ Transplant. 2018 Feb;23(1):51-62. doi: 10.1097/MOT.0000000000000496. Review.

PMID:
29176362
24.

Human regulatory T cells undergo self-inflicted damage via granzyme pathways upon activation.

Sula Karreci E, Eskandari SK, Dotiwala F, Routray SK, Kurdi AT, Assaker JP, Luckyanchykov P, Mihali AB, Maarouf O, Borges TJ, Alkhudhayri A, Patel KR, Radwan A, Ghobrial I, McGrath M, Chandraker A, Riella LV, Elyaman W, Abdi R, Lieberman J, Azzi J.

JCI Insight. 2017 Nov 2;2(21). pii: 91599. doi: 10.1172/jci.insight.91599.

25.

Integrated Kidney Exosome Analysis for the Detection of Kidney Transplant Rejection.

Park J, Lin HY, Assaker JP, Jeong S, Huang CH, Kurdi T, Lee K, Fraser K, Min C, Eskandari S, Routray S, Tannous B, Abdi R, Riella L, Chandraker A, Castro CM, Weissleder R, Lee H, Azzi JR.

ACS Nano. 2017 Nov 28;11(11):11041-11046. doi: 10.1021/acsnano.7b05083. Epub 2017 Oct 25.

26.

ASGE EndoVators Summit: Defining the role and value of endoscopic therapies in obesity management.

ASGE EndoVators Task Force, Ryou M, McQuaid KR, Thompson CC, Edmundowicz S, Mergener K, Abu Dayyeh B, Apovian C, Burke C, Chand B, Chandraker A, Deas T, Dietz W, Dunkin B, Ernest O, Faigel D, Garber S, Hamdy O, Kaplan L, Kumar N, Kushner R, Larsen MC, Lerner H, Littenberg G, Mantzoros C, Mattar S, Moore R, Rinella M, Rothstein R, Schillinger D, Spring B, Sullivan S, Tice J, Vargo J, Wilson E, Woods K, Zundel N.

Gastrointest Endosc. 2017 Nov;86(5):757-767. doi: 10.1016/j.gie.2017.08.004. Epub 2017 Oct 12. No abstract available.

PMID:
29031371
27.

ASGE EndoVators Summit: Defining the role and value of endoscopic therapies in obesity management.

Ryou M, McQuaid KR, Thompson CC, Edmundowicz S, Mergener K, Dayyeh BA, Apovian C, Burke C, Chand B, Chandraker A, Deas T, Dietz W, Dunkin B, Ernest O, Faigel D, Garber S, Hamdy O, Kaplan L, Kumar N, Kushner R, Larsen MC, Lerner H, Littenberg G, Mantzoros C, Mattar S, Moore R, Rinella M, Rothstein R, Schillinger D, Spring B, Sullivan S, Tice J, Vargo J, Wilson E, Woods K, Zundel N.

Surg Obes Relat Dis. 2017 Nov;13(11):1805-1816. doi: 10.1016/j.soard.2017.08.024. Epub 2017 Sep 8. No abstract available.

PMID:
29030161
28.

IL-6 production by monocytes is associated with graft function decline in patients with borderline changes suspicious for acute T-cell-mediated rejection: a pilot study.

Désy O, Béland S, Vallin P, Riopel J, Latulippe E, Najafian N, Chandraker A, Agharazii M, Batal I, De Serres SA.

Transpl Int. 2018 Jan;31(1):92-101. doi: 10.1111/tri.13070. Epub 2017 Sep 28.

29.

Causes and management of postrenal transplant diarrhea: an underappreciated cause of transplant-associated morbidity.

Shin HS, Chandraker A.

Curr Opin Nephrol Hypertens. 2017 Nov;26(6):484-493. doi: 10.1097/MNH.0000000000000368. Review.

PMID:
28863048
30.

Avascular necrosis of the humeral head following bilateral upper extremity vascular composite allotransplantation: a case report.

Rinkinen J, Molway D, Carty M, Dyer GSM, Pomahac B, Chandraker A, Talbot SG.

Case Reports Plast Surg Hand Surg. 2017 Jul 6;4(1):60-64. doi: 10.1080/23320885.2017.1345635. eCollection 2017.

31.

Longitudinal immunological characterization of the first presensitized recipient of a face transplant.

Win TS, Murakami N, Borges TJ, Chandraker A, Murphy G, Lian C, Barrera V, Ho Sui S, Schoenfeld D, Teague J, Bueno E, Tullius SG, Pomahac B, Clark RA, Riella LV.

JCI Insight. 2017 Jul 6;2(13). pii: 93894. doi: 10.1172/jci.insight.93894. eCollection 2017 Jul 6.

32.

The promise of organ and tissue preservation to transform medicine.

Giwa S, Lewis JK, Alvarez L, Langer R, Roth AE, Church GM, Markmann JF, Sachs DH, Chandraker A, Wertheim JA, Rothblatt M, Boyden ES, Eidbo E, Lee WPA, Pomahac B, Brandacher G, Weinstock DM, Elliott G, Nelson D, Acker JP, Uygun K, Schmalz B, Weegman BP, Tocchio A, Fahy GM, Storey KB, Rubinsky B, Bischof J, Elliott JAW, Woodruff TK, Morris GJ, Demirci U, Brockbank KGM, Woods EJ, Ben RN, Baust JG, Gao D, Fuller B, Rabin Y, Kravitz DC, Taylor MJ, Toner M.

Nat Biotechnol. 2017 Jun 7;35(6):530-542. doi: 10.1038/nbt.3889. Review.

33.

Pre-transplant immune factors may be associated with BK polyomavirus reactivation in kidney transplant recipients.

DeWolfe D, Gandhi J, Mackenzie MR, Broge TA Jr, Bord E, Babwah A, Mandelbrot DA, Pavlakis M, Cardarelli F, Viscidi R, Chandraker A, Tan CS.

PLoS One. 2017 May 31;12(5):e0177339. doi: 10.1371/journal.pone.0177339. eCollection 2017.

34.

B Cell Receptor Genes Associated With Tolerance Identify a Cohort of Immunosuppressed Patients With Improved Renal Allograft Graft Function.

Asare A, Kanaparthi S, Lim N, Phippard D, Vincenti F, Friedewald J, Pavlakis M, Poggio E, Heeger P, Mannon R, Burrell BE, Morrison Y, Bridges N, Sanz I, Chandraker A, Newell KA, Turka LA.

Am J Transplant. 2017 Oct;17(10):2627-2639. doi: 10.1111/ajt.14283. Epub 2017 May 2.

35.

Effectiveness of Integrated Care on Delaying Progression of stage 3-4 Chronic Kidney Disease in Rural Communities of Thailand (ESCORT study): a cluster randomized controlled trial.

Jiamjariyapon T, Ingsathit A, Pongpirul K, Vipattawat K, Kanchanakorn S, Saetie A, Kanistanon D, Wongprompitak P, Leesmidt V, Watcharasaksilp W, Wang W, Chandraker AK, Tungsanga K.

BMC Nephrol. 2017 Mar 2;18(1):83. doi: 10.1186/s12882-016-0414-4.

36.

Metabolomic Profiling in Individuals with a Failing Kidney Allograft.

Bassi R, Niewczas MA, Biancone L, Bussolino S, Merugumala S, Tezza S, D'Addio F, Ben Nasr M, Valderrama-Vasquez A, Usuelli V, De Zan V, El Essawy B, Venturini M, Secchi A, De Cobelli F, Lin A, Chandraker A, Fiorina P.

PLoS One. 2017 Jan 4;12(1):e0169077. doi: 10.1371/journal.pone.0169077. eCollection 2017.

37.

Acute myeloid leukemia after kidney transplantation: a case report and literature review.

Cardarelli F, Bijol V, Chandraker A, Varga C, Riella LV.

J Bras Nefrol. 2016 Dec;38(4):455-461. doi: 10.5935/0101-2800.20160072. Review. Portuguese, English.

38.

Integrating APOL1 Gene Variants Into Renal Transplantation: Considerations Arising From the American Society of Transplantation Expert Conference.

Newell KA, Formica RN, Gill JS, Schold JD, Allan JS, Covington SH, Wiseman AC, Chandraker A.

Am J Transplant. 2017 Apr;17(4):901-911. doi: 10.1111/ajt.14173. Epub 2017 Feb 2.

39.

Toll Like Receptor 2, 4, and 9 Signaling Promotes Autoregulative Tumor Cell Growth and VEGF/PDGF Expression in Human Pancreatic Cancer.

Grimmig T, Moench R, Kreckel J, Haack S, Rueckert F, Rehder R, Tripathi S, Ribas C, Chandraker A, Germer CT, Gasser M, Waaga-Gasser AM.

Int J Mol Sci. 2016 Dec 8;17(12). pii: E2060.

40.

The Presence of Pretransplant HLA Antibodies Does Not Impact the Development of Chronic Lung Allograft Dysfunction or CLAD-Related Death.

Zazueta OE, Preston SE, Moniodis A, Fried S, Kim M, Townsend K, Wood I, Boukedes S, Guleria I, Camp P, El-Chemaly S, Rosas IO, Chandraker A, Milford E, Goldberg HJ.

Transplantation. 2017 Sep;101(9):2207-2212. doi: 10.1097/TP.0000000000001494.

PMID:
27893614
41.

Live Images of Donor Dendritic Cells Trafficking via CX3CR1 Pathway.

Ueno T, Kim P, McGrath MM, Yeung MY, Shimizu T, Jung K, Sayegh MH, Chandraker AK, Abdi R, Yun SH.

Front Immunol. 2016 Oct 14;7:412. eCollection 2016.

42.

Face Transplantation in a Highly Sensitized Recipient.

Chandraker A, Arscott R, Murphy G, Lian C, Bueno E, Marty F, Rennke H, Milford E, Tullius S, Pomahac B.

Mil Med. 2016 Oct;181(10):1392. No abstract available.

PMID:
27753587
43.

Criminal Organ Retrieval: Unconscionable.

Pruett TL, Vathsala A, Berney T, Lerut J, Odorico JS, Johnson M, Egawa H, Gonzalez-Martinez F, Haberal M, Ascher NL, Chandraker AK.

Am J Transplant. 2017 Feb;17(2):577. doi: 10.1111/ajt.14028. Epub 2016 Oct 3. No abstract available.

44.

Exclusive inhibition of PI3K/Akt/mTOR signaling is not sufficient to prevent PDGF-mediated effects on glycolysis and proliferation in colorectal cancer.

Moench R, Grimmig T, Kannen V, Tripathi S, Faber M, Moll EM, Chandraker A, Lissner R, Germer CT, Waaga-Gasser AM, Gasser M.

Oncotarget. 2016 Oct 18;7(42):68749-68767. doi: 10.18632/oncotarget.11899.

45.

Imaging cell biology in transplantation.

Ueno T, Jung K, Yeung MY, McGrath MM, Shimizu T, Kim P, Sayegh MH, Chandraker A, Yun SH.

Transpl Int. 2016 Dec;29(12):1349-1351. doi: 10.1111/tri.12852. Epub 2016 Sep 29. No abstract available.

46.

Donor-specific antibodies and antibody-mediated rejection in vascularized composite allotransplantation.

Weissenbacher A, Loupy A, Chandraker A, Schneeberger S.

Curr Opin Organ Transplant. 2016 Oct;21(5):510-5. doi: 10.1097/MOT.0000000000000349. Review.

PMID:
27517505
47.

Cholesterol efflux capacity of high-density lipoprotein correlates with survival and allograft vasculopathy in cardiac transplant recipients.

Javaheri A, Molina M, Zamani P, Rodrigues A, Novak E, Chambers S, Stutman P, Maslanek W, Williams M, Lilly SM, Heeger P, Sayegh MH, Chandraker A, Briscoe DM, Daly KP, Starling R, Ikle D, Christie J, Rame JE, Goldberg LR, Billheimer J, Rader DJ.

J Heart Lung Transplant. 2016 Nov;35(11):1295-1302. doi: 10.1016/j.healun.2016.06.022. Epub 2016 Jul 15. Review.

48.

The White House Organ Summit: What It Means for Our Field.

Pruett TL, Chandraker A.

Am J Transplant. 2016 Aug;16(8):2245-6. doi: 10.1111/ajt.13947. No abstract available.

49.

Efficacy and Safety of Direct Acting Antivirals in Kidney Transplant Recipients with Chronic Hepatitis C Virus Infection.

Lin MV, Sise ME, Pavlakis M, Amundsen BM, Chute D, Rutherford AE, Chung RT, Curry MP, Hanifi JM, Gabardi S, Chandraker A, Heher EC, Elias N, Riella LV.

PLoS One. 2016 Jul 14;11(7):e0158431. doi: 10.1371/journal.pone.0158431. eCollection 2016.

50.

Face Transplantation in a Highly Sensitized Recipient.

Chandraker A, Arscott R, Murphy G, Lian C, Bueno E, Marty F, Rennke H, Milford E, Tullius S, Pomahac B.

Mil Med. 2016 May;181(5 Suppl):221-6. doi: 10.7205/MILMED-D-15-00136. Erratum in: Mil Med. 2016 Oct;181(10 ):1392.

PMID:
27168576

Supplemental Content

Loading ...
Support Center